These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 27214604

  • 1. Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs.
    Li W, Yang B, Zhou D, Xu J, Ke Z, Suen WC.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul 01; 1025():57-67. PubMed ID: 27214604
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
    Gahoual R, Biacchi M, Chicher J, Kuhn L, Hammann P, Beck A, Leize-Wagner E, François YN.
    MAbs; 2014 Jul 01; 6(6):1464-73. PubMed ID: 25484058
    [Abstract] [Full Text] [Related]

  • 3. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
    Sorensen M, Harmes DC, Stoll DR, Staples GO, Fekete S, Guillarme D, Beck A.
    MAbs; 2016 Oct 01; 8(7):1224-1234. PubMed ID: 27362833
    [Abstract] [Full Text] [Related]

  • 4. Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells.
    Li Y, Fu T, Liu T, Guo H, Guo Q, Xu J, Zhang D, Qian W, Dai J, Li B, Guo Y, Hou S, Wang H.
    MAbs; 2016 Jul 01; 8(5):951-60. PubMed ID: 27050807
    [Abstract] [Full Text] [Related]

  • 5. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development.
    Brady LJ, Velayudhan J, Visone DB, Daugherty KC, Bartron JL, Coon M, Cornwall C, Hinckley PJ, Connell-Crowley L.
    MAbs; 2015 Jul 01; 7(3):562-70. PubMed ID: 25898160
    [Abstract] [Full Text] [Related]

  • 6. Microfluidic capillary electrophoresis - mass spectrometry for rapid charge-variant and glycoform assessment of monoclonal antibody biosimilar candidates.
    Cageling R, Carillo S, Boumeester AJ, Lubbers-Geuijen K, Bones J, Jooß K, Somsen GW.
    J Pharm Biomed Anal; 2024 Sep 15; 248():116301. PubMed ID: 38901155
    [Abstract] [Full Text] [Related]

  • 7. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
    Zhu L, Guo Q, Guo H, Liu T, Zheng Y, Gu P, Chen X, Wang H, Hou S, Guo Y.
    MAbs; 2014 Sep 15; 6(6):1474-85. PubMed ID: 25484062
    [Abstract] [Full Text] [Related]

  • 8. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
    Xie H, Chakraborty A, Ahn J, Yu YQ, Dakshinamoorthy DP, Gilar M, Chen W, Skilton SJ, Mazzeo JR.
    MAbs; 2010 Sep 15; 2(4):379-94. PubMed ID: 20458189
    [Abstract] [Full Text] [Related]

  • 9. A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics.
    Chen SL, Wu SL, Huang LJ, Huang JB, Chen SH.
    J Pharm Biomed Anal; 2013 Jun 15; 80():126-35. PubMed ID: 23563225
    [Abstract] [Full Text] [Related]

  • 10. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.
    Beck A, Debaene F, Diemer H, Wagner-Rousset E, Colas O, Van Dorsselaer A, Cianférani S.
    J Mass Spectrom; 2015 Feb 15; 50(2):285-97. PubMed ID: 25800010
    [Abstract] [Full Text] [Related]

  • 11. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.
    D'Atri V, Fekete S, Beck A, Lauber M, Guillarme D.
    Anal Chem; 2017 Feb 07; 89(3):2086-2092. PubMed ID: 28208257
    [Abstract] [Full Text] [Related]

  • 12. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
    Jakes C, Millán-Martín S, Carillo S, Scheffler K, Zaborowska I, Bones J.
    J Am Soc Mass Spectrom; 2021 Aug 04; 32(8):1998-2012. PubMed ID: 33513021
    [Abstract] [Full Text] [Related]

  • 13. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
    Beck A, Bussat MC, Zorn N, Robillard V, Klinguer-Hamour C, Chenu S, Goetsch L, Corvaïa N, Van Dorsselaer A, Haeuw JF.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May 25; 819(2):203-18. PubMed ID: 15833284
    [Abstract] [Full Text] [Related]

  • 14. Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.
    Dyck YFK, Rehm D, Winkler K, Sandig V, Jabs W, Parr MK.
    J Pharm Biomed Anal; 2023 Oct 25; 235():115596. PubMed ID: 37540995
    [Abstract] [Full Text] [Related]

  • 15. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody.
    Ren D, Zhang J, Pritchett R, Liu H, Kyauk J, Luo J, Amanullah A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct 01; 879(27):2877-84. PubMed ID: 21900054
    [Abstract] [Full Text] [Related]

  • 16. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.
    Duivelshof BL, Jiskoot W, Beck A, Veuthey JL, Guillarme D, D'Atri V.
    Anal Chim Acta; 2019 Dec 16; 1089():1-18. PubMed ID: 31627805
    [Abstract] [Full Text] [Related]

  • 17. [Structural characterization and analysis of Omalizumab and its biosimilar CMAB007 by LC-MS].
    Xu J, Zhang D, Wang H, Guo H.
    Sheng Wu Gong Cheng Xue Bao; 2016 Apr 25; 32(4):497-506. PubMed ID: 28853271
    [Abstract] [Full Text] [Related]

  • 18. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
    Wang D, Wynne C, Gu F, Becker C, Zhao J, Mueller HM, Li H, Shameem M, Liu YH.
    Anal Chem; 2015 Jan 20; 87(2):914-21. PubMed ID: 25513708
    [Abstract] [Full Text] [Related]

  • 19. A comprehensive approach for evaluating charge heterogeneity in biosimilars.
    Xiao Z, Yin X, Han L, Sun B, Shen Z, Liu W, Yu F.
    Eur J Pharm Sci; 2018 Mar 30; 115():19-24. PubMed ID: 29325754
    [Abstract] [Full Text] [Related]

  • 20. Characterization of monoclonal antibody size variants containing extra light chains.
    Lu C, Liu D, Liu H, Motchnik P.
    MAbs; 2013 Mar 30; 5(1):102-13. PubMed ID: 23255003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.